-
Latest News
- Healthcare: Caring for the patient with severe or very severe ME/CFS
- NICE will announce guideline decision next week
- Research review: Potential implications of TRPM7 in ME/CFS
- Diagnostic test research: Autoantibodies & receptors correlate with symptom severity, autonomic dysfunction & disability in ME/CFS
- House of Lords Q&A: NICE & ME/CFS
Archives
Tag Archives: pharmacogenomics
Treatment avenues in ME/CFS: a split-gender pharmacogenomic study of gene-expression
Treatment avenues in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: a split-gender pharmacogenomic study of gene-expression modules, by Mary G Jeffrey, Lubov Nathanson, Kristina Aenlle, Zachary M Barnes, Mirza Baig, Gordon Broderick, Nancy G Klimas, Mary Ann Fletcher, Travis JA Craddock in Clinical … Continue reading →
Posted in News
|
Tagged bioinformatics, Dr Nancy Klimas, drug repositioning, Gordon Broderick, immune dysregulation, immunosuppressants, Kistina Aenlle, Lubov Nathanson, Mary Ann Fletcher, Mary G Jeffrey, Mirza Baig, pharmacogenomics, Travis JA Craddock, treatments, Zachary Barnes
|
Comments Off on Treatment avenues in ME/CFS: a split-gender pharmacogenomic study of gene-expression
